Bristol-Myers Squibb
BMY
BMY
1,811 hedge funds and large institutions have $61.5B invested in Bristol-Myers Squibb in 2019 Q1 according to their latest regulatory filings, with 196 funds opening new positions, 722 increasing their positions, 667 reducing their positions, and 129 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,811
Holders Change
+48
Holders Change %
+2.72%
% of All Funds
39.26%
Holding in Top 10
42
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+2.44%
% of All Funds
0.91%
New
196
Increased
722
Reduced
667
Closed
129
Calls
$3.19B
Puts
$2.69B
Net Calls
+$497M
Net Calls Change
+$509M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.48B |
| 2 |
Charles Schwab
San Francisco,
California
|
+$288M |
| 3 |
Renaissance Technologies
New York
|
+$258M |
| 4 |
Two Sigma Advisers
New York
|
+$252M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$236M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$466M |
| 2 |
D.E. Shaw & Co
New York
|
-$390M |
| 3 |
BlackRock
New York
|
-$379M |
| 4 |
Harris Associates
Chicago,
Illinois
|
-$305M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$230M |
